Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Helen A. Quartuccio
Observed names:
H A Quartuccio,
H. Quartuccio,
H.A. Quartuccio
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Observed institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
OpenAlex ID:
A5110163328
The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
1991
·
J. Gregory Seedor
, Helen A. Quartuccio
, et al.
·
Journal of Bone and Mineral Research
·
414
Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein
1993
·
J E Fisher
, M P Caulfield
, et al.
·
Endocrinology
·
154
Pattern of gene expression following rat tibial marrow ablation
1993
·
Larry J. Suva
, Gregory J. Seedor
, et al.
·
Journal of Bone and Mineral Research
·
146
Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats
1992
·
B.C. Toolan
, M. Shea
, et al.
·
Journal of Bone and Mineral Research
·
124
Impaired bone activity in aged rats: Alterations at the cellular and molecular levels
1992
·
C.T. Liang
, J. Barnes
, et al.
·
Bone
·
113
Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys
1994
·
M. Weinreb
, H. Quartuccio
, et al.
·
Journal of Periodontal Research
·
104
The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons
1992
·
D.D. Thompson
, J.G. Seedor
, et al.
·
Journal of Bone and Mineral Research
·
103
Inhibition of Osteoclastic Bone Resorption in Vivo by Echistatin, an “Arginyl-Glycyl-Aspartyl” (RGD)-Containing Protein
1993
·
John E. Fisher
, Michael P. Caulfield
, et al.
·
Obstetrical & Gynecological Survey
The effect of two years alendronate treatment on biochemical markers of bone metabolism in ovariectomized baboons
1992
·
R. Balena
, E.E. Opas
, et al.
·
Bone and Mineral
Show more works
View as search
Works count:
9
Citation count:
1,158
H-index:
7
I10-index:
7
Year
Topic
Type